The forecast for Peptic Ulcer and GORD medicine sales in Germany reveals a gradual decline from $8.9 in 2024 to $8.4 in 2028 in US Dollars PPP Per Capita. In 2023, the sales were recorded at $9.0. The year-on-year decrease starts with a 2.2% decline from 2024 to 2025 and progressively lessens to approximately 1.2% by 2028. Over the five-year horizon from 2024 to 2028, the compound annual growth rate (CAGR) reflects a consistent average annual decrease.

Future trends to watch for include:

Potential impact of new treatment innovations on sales volumes.
Influence of healthcare policy changes on accessibility and affordability.
Shifts in demographics that may affect prevalence rates of these conditions.
Development in patient awareness and lifestyle modifications reducing disease incidence.